Literature DB >> 30526265

Utilization of 1,3-Dioxolanes in the Synthesis of α-branched Alkyl and Aryl 9-[2-(Phosphonomethoxy)Ethyl]Purines and Study of the Influence of α-branched Substitution for Potential Biological Activity.

Karel Pomeisl1,2, Radek Pohl1, Robert Snoeck3, Graciela Andrei3, Marcela Krečmerová1.   

Abstract

Syntheses of α-branched alkyl and aryl substituted 9-[2-(phosphonomethoxy)ethyl]purines from substituted 1,3-dioxolanes have been developed. Key synthetic precursors, α-substituted dialkyl [(2-hydroxyethoxy)methyl]phosphonates were prepared via Lewis acid mediated cleavage of 1,3-dioxolanes followed by reaction with dialkyl or trialkyl phosphites. The best preparative yields were achieved under conditions utilizing tin tetrachloride as Lewis acid and triisopropyl phosphite. Attachment of purine bases to dialkyl [(2-hydroxyethoxy)methyl]phosphonates was performed by Mitsunobu reaction. Final α-branched 9-[2-(phosphonomethoxy)ethyl]purines were tested for antiviral, cytostatic and antiparasitic activity, the latter one determined as inhibitory activity towards Plasmodium falciparum enzyme hypoxanthine-guanine-xanthine phosphoribosyltransfesase. In most cases biological activity was only marginal.

Entities:  

Keywords:  1,3-dioxolanes; Acyclic nucleoside phosphonates; PEEG; PMEG; dialkyl phosphite; trialkyl phosphite

Mesh:

Substances:

Year:  2018        PMID: 30526265     DOI: 10.1080/15257770.2018.1506884

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  1 in total

1.  Synthesis of Pyrimidine Conjugates with 4-(6-Amino-hexanoyl)-7,8-difluoro-3,4-dihydro-3-methyl-2H-[1,4]benzoxazine and Evaluation of Their Antiviral Activity.

Authors:  Victor P Krasnov; Vera V Musiyak; Galina L Levit; Dmitry A Gruzdev; Valeriya L Andronova; Georgii A Galegov; Iana R Orshanskaya; Ekaterina O Sinegubova; Vladimir V Zarubaev; Valery N Charushin
Journal:  Molecules       Date:  2022-06-30       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.